CAS RN: 13845-18-6
Sodium Sulfamate
Product Availability
Choose a grade to view its available package options.
4 package records 4 with current stock 1 grade group
Grade
95% (4)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250613
100g
In stock
Shanghai, Shenzhen, Tianjin, Wuhan Inquiry
Batchno.20250303
1kg
In stock
Shanghai, Tianjin Inquiry
Batchno.20250306
25g
In stock
Shanghai, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250827
500g
In stock
Shanghai, Shenzhen Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 500g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 13845-18-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
500g
≥97%
0
Out of Stock
Hong Kong
Inquiry
13845-18-6 / sodium sulfamate
Standard CAS: 13845-18-6
Multi CAS: No
Basic Information
copy
CAS
13845-18-6 copy
Multi CAS
No copy
Molecular Formula
H2NNaO3S copy
Molecular Weight
119.080000 copy
Exact Mass
118.965308 copy
SMILES
NS(=O)(=O)[O-].[Na+] copy
InChI
InChI=1S/H3NO3S.Na/c1-5(2,3)4;/h(H3,1,2,3,4);/q;+1/p-1 copy
InChIKey
QDWYPRSFEZRKDK-UHFFFAOYSA-M copy
Physical Properties
copy
Physical Description
Dry Powder; Liquid
Hygroscopic solid copy
State
Solid copy
Computed Properties
copy
Structural Parameters
Heavy atom count
6 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
13.88 copy
TPSA
83.22 copy
LogP / Solubility
WLOGP
-4.59 copy
MLOGP
-4.05 copy
XLogP3
-4.59 copy
Consensus LogP
-4.41 copy
Log S (ESOL)
2.31 copy
Class (ESOL)
Highly soluble copy
Log S (Ali)
2.78 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
3.38 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-6.71 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 119 of 120 companies (only 0.8% companies provided GHS information). For more detailed information, please visit ECHA C&L website.
Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website. copy